Allergy Therapeutics plc (LON:AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, has announced that company management will participate in a fireside chat at the upcoming H.C. Wainwright Global Investment Conference being held September 12-14, 2022, in New York, NY and virtually.
The virtual fireside chat will be available to registered attendees of the conference for on-demand viewing beginning September 12, 2022 at 9:00 a.m. ET/2:00 p.m. BST. A replay of the presentation will be made available under the ‘Investors’ section on Allergy Therapeutics’ website at www.allergytherapeutics.com/investors/results-reports-and-presentations/.